GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OKYO Pharma Ltd (LSE:OKYO) » Definitions » Shiller PE Ratio

OKYO Pharma (LSE:OKYO) Shiller PE Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2018. Start your Free Trial

What is OKYO Pharma Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


OKYO Pharma Shiller PE Ratio Historical Data

The historical data trend for OKYO Pharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OKYO Pharma Shiller PE Ratio Chart

OKYO Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OKYO Pharma Semi-Annual Data
Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OKYO Pharma's Shiller PE Ratio

For the Biotechnology subindustry, OKYO Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OKYO Pharma's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OKYO Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where OKYO Pharma's Shiller PE Ratio falls into.



OKYO Pharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

OKYO Pharma's E10 for the fiscal year that ended in Mar23 is calculated as:

For example, OKYO Pharma's adjusted earnings per share data for the fiscal year that ended in Mar23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar23 (Change)*Current CPI (Mar23)
=0/126.8000*126.8000
=0.000

Current CPI (Mar23) = 126.8000.

OKYO Pharma Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.017 99.300 -0.022
201503 -0.010 99.600 -0.013
201603 -0.001 100.400 -0.001
201703 -0.001 102.700 -0.001
201803 -0.036 105.100 -0.043
201903 -0.008 107.000 -0.009
202003 -0.002 108.600 -0.002
202103 -0.005 109.700 -0.006
202203 -0.006 116.500 -0.007
202303 0.000 126.800 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OKYO Pharma  (LSE:OKYO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


OKYO Pharma Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of OKYO Pharma's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OKYO Pharma (LSE:OKYO) Business Description

Traded in Other Exchanges
Address
14/15 Conduit St, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.